These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11930465)

  • 1. The use of low molecular weight heparin in the initial management of patients with deep vein thrombosis.
    Betten KC
    J Am Acad Nurse Pract; 2000 Jul; 12(7):267-72. PubMed ID: 11930465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment and prophylaxis of deep venous thrombosis with low molecular weight heparins (meta-analysis of clinical trials)].
    Valiukiene L; Naudziūnas A; Unikauskas A
    Medicina (Kaunas); 2003; 39(4):352-8. PubMed ID: 12738903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tinzaparin in the treatment of venous thromboembolism.
    Pineo GF; Hull RD
    Expert Opin Pharmacother; 2003 Dec; 4(12):2355-62. PubMed ID: 14640933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Home treatment of venous thrombosis. "For and against"].
    Ben Khalfallah A; Annabi N
    Tunis Med; 2003 Nov; 81(11):847-53. PubMed ID: 14986538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous unfractionated heparin compared with low-molecular-weight heparin for the initial treatment of venous thromboembolism.
    Bernardi E; Prandoni P
    Curr Opin Pulm Med; 2005 Sep; 11(5):363-7. PubMed ID: 16093806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis.
    Gould MK; Dembitzer AD; Sanders GD; Garber AM
    Ann Intern Med; 1999 May; 130(10):789-99. PubMed ID: 10366368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic considerations in the prevention and treatment of venous thromboembolism.
    Hawkins D
    Am J Health Syst Pharm; 2004 Dec; 61(23 Suppl 7):S18-21. PubMed ID: 15597575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticoagulation in patients with venous thromboembolism].
    Rüfer A; Wuillemin WA
    Ther Umsch; 2003 Jan; 60(1):43-7. PubMed ID: 12638478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness of tinzaparin sodium versus unfractionated heparin in the treatment of proximal deep vein thrombosis.
    Caro JJ; Getsios D; Caro I; O'Brien JA
    Pharmacoeconomics; 2002; 20(9):593-602. PubMed ID: 12141887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of low-molecular-weight heparin in the treatment of proximal deep vein thrombosis.
    Estrada CA; Mansfield CJ; Heudebert GR
    J Gen Intern Med; 2000 Feb; 15(2):108-15. PubMed ID: 10672114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis.
    Rodger M; Bredeson C; Wells PS; Beck J; Kearns B; Huebsch LB
    CMAJ; 1998 Oct; 159(8):931-8. PubMed ID: 9834718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outpatient treatment of acute venous thromboembolic disease.
    Yusen RD; Gage BF
    Clin Chest Med; 2003 Mar; 24(1):49-61. PubMed ID: 12685056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies comparing low molecular weight heparin with heparin for the treatment of thromboembolism: a literature review.
    Messmore HL; Coyne E; Wehrmacher WH; Demir AM; Fareed J
    Curr Pharm Des; 2004; 10(9):1001-10. PubMed ID: 15078129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
    Ruiz Manzano J; Monreal M
    Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of deep venous thrombosis at home].
    Melin J; Koskinen P; Naukkarinen V
    Duodecim; 2001; 117(24):2627-30. PubMed ID: 12183825
    [No Abstract]   [Full Text] [Related]  

  • 16. Community-based treatment of venous thromboembolism with a low-molecular-weight heparin and warfarin.
    Hyers TM; Spyropoulos AC;
    J Thromb Thrombolysis; 2007 Dec; 24(3):225-32. PubMed ID: 17334932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation.
    Huse DM; Cummins G; Taylor DC; Russell MW
    Am J Manag Care; 2002 Jan; 8(1 Suppl):S10-6. PubMed ID: 11822346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-minimization analysis of low-molecular-weight heparin (dalteparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosis.
    Avritscher EB; Cantor SB; Shih YC; Escalante CP; Rivera E; Elting LS
    Support Care Cancer; 2004 Jul; 12(7):531-6. PubMed ID: 14986076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient therapy with low molecular weight heparin for the treatment of venous thromboembolism: a review of efficacy, safety, and costs.
    Segal JB; Bolger DT; Jenckes MW; Krishnan JA; Streiff MB; Eng J; Tamariz LJ; Bass EB
    Am J Med; 2003 Sep; 115(4):298-308. PubMed ID: 12967695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis.
    Belcaro G; Nicolaides AN; Cesarone MR; Laurora G; De Sanctis MT; Incandela L; Barsotti A; Corsi M; Vasdekis S; Christopoulos D; Lennox A; Malouf M
    Angiology; 1999 Oct; 50(10):781-7. PubMed ID: 10535716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.